Work Smart, Build Trust: Connecting Technology, Patient Compliance and Data Processing
16 Oct 2025
14m
BioSpace · Business
BioSpace
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Episodes
Q3 Earnings Are Here, Novo Ditches Cell Therapy but Buys Akero, Gov’t Shutdown Hits CDC
15 Oct 2025
27m
Bonus: Q3 2025 Job Market Update
14 Oct 2025
11m
Shutdown Pauses New Drug Reviews, CDC Issues New COVID Guidance, CGT Meets on Mesa
08 Oct 2025
29m
Hit Me With Your Best Shot: Understanding Autoinjectors and Combination Drug Delivery Systems
02 Oct 2025
18m
M&A Picks Up, Walmsley Moves On, Pfizer’s MFN Deal and Hope for Huntington’s
01 Oct 2025
22m
FDA’s Autism Endeavor, Pfizer’s Obesity Comeback Bid, Psychedelics Revival, ACIP Confusion, More
24 Sep 2025
32m
What Do AI and Hammers Have in Common?
18 Sep 2025
22m
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
17 Sep 2025
27m
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More
10 Sep 2025
32m
The 'Research Safety Net' Saving Scientists from Funding Crisis
04 Sep 2025
17m
CDC Faces Critical Meetings Amid COVID Vaccine Uncertainty, Plus Deals, FDA Approvals, More
03 Sep 2025
31m
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
27 Aug 2025
22m
Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations
26 Aug 2025
17m
Why AI Won't Save the 90% of Clinical Trials That Still Fail
21 Aug 2025
24m
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
20 Aug 2025
29m
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
14 Aug 2025
25m
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
13 Aug 2025
22m
From Chat Bots to World Order: The Race for the 21st Century's Operating System
07 Aug 2025
20m
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
06 Aug 2025
26m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.